Arkansas has approximately 150 licensed substance abuse treatment facilities and recorded over 700 drug overdose deaths in 2023. Methamphetamine is the primary substance of concern across the state, particularly in rural areas. The Division of Aging, Adult, and Behavioral Health Services (DAABHS) within the Department of Human Services oversees Arkansas's publicly funded substance abuse treatment system through contracted community providers.
Substance Abuse Statistics in Arkansas
According to NSDUH data, approximately 7.6% of Arkansas adults reported a substance use disorder in the past year. Unlike many neighboring states where opioids dominate, methamphetamine has long been the most frequently cited substance in Arkansas treatment admissions. However, fentanyl-involved overdose deaths have increased sharply in recent years, particularly in urban areas like Little Rock, Fort Smith, and Northwest Arkansas.
Alcohol remains the most commonly misused substance overall, accounting for approximately 26% of all treatment admissions. Prescription drug misuse, particularly opioids and benzodiazepines, continues to be a significant concern in rural communities.
Types of Treatment Programs Available
Medical Detox: Medically supervised detox facilities are available in Little Rock, Northwest Arkansas (Fayetteville-Rogers-Springdale), Fort Smith, Jonesboro, and Pine Bluff. Programs provide 24/7 medical monitoring during the withdrawal phase. Access in rural areas is limited, often requiring patients to travel to urban centers.
Residential/Inpatient Treatment: Arkansas has approximately 50 residential treatment facilities ranging from short-term to long-term programs. DAABHS contracts with community-based providers to deliver state-funded residential services. Evidence-based modalities include CBT, 12-step facilitation, trauma-informed care, and therapeutic community models.
Outpatient Programs: IOPs and standard outpatient services are available through community mental health centers and private providers. Arkansas Medicaid covers outpatient SUD services including individual and group counseling, peer support, and case management.
Medication-Assisted Treatment (MAT): Arkansas has approximately 30 Opioid Treatment Programs and a growing network of buprenorphine prescribers. The state has focused on expanding MAT access in underserved rural communities through telehealth services. Arkansas Medicaid covers methadone, buprenorphine, and naltrexone.
Arkansas's Medicaid Expansion
Arkansas expanded Medicaid under the ACA in 2014 through the innovative "Arkansas Works" program (formerly the Private Option), which uses Medicaid funds to purchase private insurance for eligible adults. This expansion has significantly increased access to substance abuse treatment for over 300,000 previously uninsured adults. Coverage includes the full continuum of SUD care including assessment, detox, residential treatment, outpatient counseling, and MAT.
Insurance & Payment Options
Medicaid: Arkansas Medicaid (Arkansas Works) covers SUD treatment for eligible adults earning up to 138% of the federal poverty level. Coverage includes assessment, detox, residential, outpatient, and MAT services through participating managed care plans.
Private Insurance: Major carriers including Arkansas Blue Cross Blue Shield, QualChoice, Ambetter, and UnitedHealthcare cover SUD treatment under federal parity requirements. Verify your insurance to explore your options.
State-Funded Programs: DAABHS funds treatment through contracted community providers. Uninsured individuals can access state-funded services on a sliding-fee scale.
Finding Help in Arkansas
SAMHSA National Helpline: Call 1-800-662-4357 for free, confidential, 24/7 referrals.
Arkansas Crisis Center: Call 1-888-274-7472 for statewide crisis support and substance abuse referrals, available 24/7.
211 Arkansas: Dial 211 for local resource referrals including treatment programs, support groups, and emergency services.